Press release
At a CAGR 11.8%, Companion Diagnostics Market is expected to reach over US$ 18.0 Billion by 2031
Get Access to A Free Sample Copy of Our Latest Report @ https://www.globalinsightservices.com/request-sample/GIS10261
This market has grown significantly in recent years, reflecting the healthcare industry's shift towards personalized medicine and the increasing recognition of the value of targeted therapies. Several factors are contributing to the expansion of the companion diagnostics market. The rise in precision medicine, which aims to customize treatment based on the patient's genetic information, is a major driver. Pharmaceutical companies are increasingly partnering with diagnostic firms to develop companion diagnostics alongside new drug therapies, ensuring that the right patient receives the right treatment. Additionally, the growing prevalence of complex diseases such as cancer, along with the need for more effective and personalized treatment approaches, has spurred the demand for companion diagnostics. As research and technological advancements continue to uncover the intricacies of disease biology, the companion diagnostics market is poised for further growth, promising improved patient care and more efficient drug development processes.
Read Full Research Report @ https://www.globalinsightservices.com/reports/cancer-diagnostics-market/
Key Trends
The Companion Diagnostics Market is characterized by dynamic trends that are reshaping the landscape of personalized medicine and patient care. Rapid advancements in genomics and molecular biology have led to an increased emphasis on identifying specific biomarkers and genetic mutations, fueling the development of companion diagnostics. The integration of next-generation sequencing and advanced imaging technologies is enhancing the accuracy and breadth of diagnostic information, enabling healthcare providers to make more informed treatment decisions. The rise of immunotherapy and targeted therapies further underscores the importance of companion diagnostics in identifying patients who are likely to respond positively to specific treatments.
Buy Now @ https://www.globalinsightservices.com/checkout/single_user/GIS10252
Key Drivers
The Companion Diagnostics Market is propelled by key drivers that are reshaping the field of personalized medicine and transforming patient care. The increasing demand for more effective and targeted therapies is spurring the development of companion diagnostics, as healthcare providers seek to optimize treatment outcomes and minimize adverse effects. Regulatory agencies' growing emphasis on evidence-based medicine and therapy effectiveness is driving the integration of companion diagnostics into clinical decision-making processes. Collaborations between pharmaceutical companies, diagnostic developers, and research institutions are accelerating innovation, resulting in the co-development of therapies and their corresponding diagnostics.
Request for Customization @ https://www.globalinsightservices.com/request-customization/GIS10261
Market Segmentation : Companion Diagnostics Market
Companion Diagnostics Market By Products & Services : Assays, Kits & Reagents, Software & Service
Companion Diagnostics Market By Technology : Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry, Other
Companion Diagnostics Market By Indication : Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others
Companion Diagnostics Market By End User : Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations
Companion Diagnostics Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa
Key Players
F. Hoffmann-La Roche Ltd. (Switzerland)
Agilent Technologies, Inc. (US)
Qiagen N.V. (Germany)
Thermo Fisher Scientific, Inc. (US)
Abbott Laboratories, Inc. (US)
Almac Group (UK)
Danaher Corporation (US)
Illumina Inc. (US)
bioMérieux SA (France)
Myriad Genetics, Inc. (US)
Sysmex Corporation (Japan)
Abnova Corporation (Taiwan)
Guardant Health, Inc. (US)
New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Contact Us :
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services :
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At a CAGR 11.8%, Companion Diagnostics Market is expected to reach over US$ 18.0 Billion by 2031 here
News-ID: 3204941 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
